APA (7th ed.) Citation

OS, B., AG, M., LD, M., IG, M., MS, M., ED, K., . . . S, K. (2026). Long term administration of selective NMDA GluN2B receptor blocker Ro25-6981 attenuates neurodegeneration in mouse model of spinocerebellar ataxia type 1 (SCA1). Cell death discovery, 12(1), . https://doi.org/10.1038/s41420-026-03120-z

Chicago Style (17th ed.) Citation

OS, Belozor, et al. "Long Term Administration of Selective NMDA GluN2B Receptor Blocker Ro25-6981 Attenuates Neurodegeneration in Mouse Model of Spinocerebellar Ataxia Type 1 (SCA1)." Cell Death Discovery 12, no. 1 (2026). https://doi.org/10.1038/s41420-026-03120-z.

MLA (9th ed.) Citation

OS, Belozor, et al. "Long Term Administration of Selective NMDA GluN2B Receptor Blocker Ro25-6981 Attenuates Neurodegeneration in Mouse Model of Spinocerebellar Ataxia Type 1 (SCA1)." Cell Death Discovery, vol. 12, no. 1, 2026, https://doi.org/10.1038/s41420-026-03120-z.